Neurofibroma - 181 Studies Found
Completed |
: Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas :
|
Active, not recruiting |
: Medical Treatment of "High-Risk" Neurofibromas : Neurofibromatosis 1 : 2009-01-16 :
|
Active, not recruiting |
: How Neurofibromatosis Type 1 (NF1) Affects Schoolwork and Self-Esteem : Neurofibromatosis Type 1 : 2012-06-21 |
Completed |
: Quality of Friendships in Children With Neurofibromatosis : Neurofibromatosis : 2007-07-26 : Behavioral: Questionnaire Questionnaire about the patient's relationship with their best friend. |
Suspended |
: Study of Sutent®/Sunitinib (SU11248) in Subjects With NF-1 Plexiform Neurofibromas :
|
Completed |
: R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas :
: 2006-06-19 :
|
Completed |
: Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas :
: 2004-01-13 : Drug: Pirfenidone Pirfenidone orally as capsules three times a day approximately every 8 hours for cycle |
Active, not recruiting |
: Study of PEG-Intron for Plexiform Neurofibromas : Plexiform Neurofibroma : 2006-11-02 : Drug: PEG-Intron |
Recruiting |
: Study of Imatinib Mesylate in Neurofibromatosis Type I Patients Aged 2 to 21 With Plexiform Neurofibromas : Plexiform Neurofibromas : 2014-06-25 : Drug: Imatinib Mesylate oral administration Other Na |
Terminated |
: Efficacy and Safety of RAD001 in Treating Plexiform Neurofibromas (PN) Associated With Neurofibromatosis (NF1) : Plexiform Neurofibroma Associated With Neurofibromatosis Type 1 : 2011-05-27 : Drug: Everolimus (RAD001) oral daily dosing of tablet starting with 2.5 mg |